Cannara Biotech Inc. (LOVFF)
Cannara Biotech Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Saint-Laurent, QC, CA. The stock last traded at $1.42, down 0.84% on the session, giving a market capitalisation of $140.3M. On trailing twelve-month figures it carries a trailing P/E of 18.15, a net margin of 9.2%. Its beta of 0.37 implies it has historically moved less than the broad market.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Cannara Biotech Inc. is most often compared with the following Healthcare names: